← Back to Search

Wearable short wavelength light therapy for Tourette Syndrome

N/A

Waitlist Available

Led By Emily J Ricketts, PhD

Research Sponsored by University of California, Los Angeles

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 2 weeks

Awards & highlights

Study Summary

This trial looks at whether a wearable light therapy device can help improve symptoms in young people with Tourette's Disorder by regulating their circadian rhythms.

Eligible Conditions

Tourette Syndrome

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 2 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~2 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Dim Light Melatonin Onset

Yale Global Tic Severity Scale (YGTSS)

Secondary outcome measures

Children's Morningness-Eveningness Preferences Scale (CMEP)

Clinical Global Impression-Improvement (CGI-I) Scale

Parent Tic Questionnaire (PTQ)

Trial Design

1Treatment groups

Experimental Treatment

Group I: Wearable short wavelength light therapyExperimental Treatment1 Intervention

Wearable short wavelength light therapy

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of California, Los AngelesLead Sponsor

1,528 Previous Clinical Trials

10,276,816 Total Patients Enrolled

4 Trials studying Tourette Syndrome

200 Patients Enrolled for Tourette Syndrome

National Institute of Mental Health (NIMH)NIH

2,782 Previous Clinical Trials

2,689,072 Total Patients Enrolled

13 Trials studying Tourette Syndrome

3,304 Patients Enrolled for Tourette Syndrome

Emily J Ricketts, PhDPrincipal InvestigatorUniversity of California, Los Angeles

2 Previous Clinical Trials

45 Total Patients Enrolled

2 Trials studying Tourette Syndrome

45 Patients Enrolled for Tourette Syndrome

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who qualifies to partake in this clinical research endeavor?

"This research seeks 35 adolescents aged 13-17 suffering from tic disorders, who must meet the following criteria to be eligible: a DSM-5 diagnosis of Tourette's Disorder, Persistent Motor Tic Disorder or Persistent Vocal Tic Disorder; Yale Global Tic Severity Scale Score ≥ 14 for Tourette's Disorder or ≥ 10 for either PMTD/PVTD; and fluency in English."

Answered by AI

Has this research endeavor commenced recruiting participants?

"The data provided by clinicaltrials.gov reveals that, at the present moment, this particular medical study is not recruiting patients. The trial was posted on January 18th 2018 and last edited on August 10th 2022. Despite this, 39 other trials are presently enrolling individuals into their studies."

Answered by AI